Skip to main content

Tenet upgraded by Soleil, shares rise

 |  By HealthLeaders Media Staff  
   December 04, 2009

Soleil Securities upgraded Tenet Healthcare to "buy" from "hold" with a price target of $6.25. Tenet has recently begun a strong recovery from seven years of bad credit stemming from Medicare fraud, the brokerage firm said. Soleil said that for the first time in a year all the hospital stocks outperformed consensus expectations on the EPS, revenue, and EBITDA lines.

Full story

Tagged Under:


Get the latest on healthcare leadership in your inbox.